Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivus
Vivus
Vivus Taps Into More Cash
Seeking Alpha
Sun, 05/19/13 - 11:16 am
Vivus
Qsymia
Will Obesity Drugs Gain Soon?
Motley Fool
Wed, 05/15/13 - 09:50 am
obesity
Novo Nordisk
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Contrave
Qsymia
Victoza
Deal Discussions Distract From Disappointing Obesity Drug Sales (video)
Motley Fool
Sun, 05/12/13 - 10:55 am
Arena Pharmaceuticals
Vivus
obesity
weight loss
Obesity Drug Demand Still Low
Motley Fool
Thu, 05/9/13 - 09:32 am
obesity
Vivus
Arena Pharmaceuticals
Qsymia
Belviq
Eisai
Vivus reports weak sales of diet pill Qsymia
Reuters
Wed, 05/8/13 - 09:27 am
Vivus
earnings
[video]Are Obesity Drugs a Lost Cause in Europe?
Motley Fool
Mon, 05/6/13 - 09:20 am
obesity
Europe
Vivus
Arena Pharmaceuticals
Qsymia
Belviq
Arena Falls, Pulls Anti-Obesity Application In Europe
Seeking Alpha
Fri, 05/3/13 - 08:56 am
Arena Pharmaceuticals
Europe
Belviq
earnings
Vivus
Vivus And Anti-Obesity Sector Benefit From New Insurance Deal
Seeking Alpha
Wed, 05/1/13 - 09:54 am
Vivus
obesity
Orexigen
Arena Pharmaceuticals
Qsymia
Medco
Exciting Catalysts Approaching for This Bet
Motley Fool
Sun, 04/28/13 - 12:07 pm
obesity
weight loss
Arena Pharmaceuticals
Vivus
Orexigen
Belviq
Qsymia
VIVUS receives positive recommendation from CHMP supporting Avanafil approval in EU
The Fly on the Wall
Fri, 04/26/13 - 11:03 am
Avanafil
Vivus
erectile dysfunction
Europe
Arena Faces A Convergence Of DEA And European Decisions
Seeking Alpha
Wed, 04/24/13 - 10:25 am
Arena Pharmaceuticals
Europe
DEA
Eisai
Vivus
Orexigen
Vivus Seeing Traction With Qsymia
Seeking Alpha
Fri, 04/19/13 - 11:53 am
Qsymia
Vivus
Orexigen
Arena Pharmaceuticals
obesity
Vivus Gets Restrictions Loosened; Will Be Available in Retail Pharmacies Later This Year
Seeking Alpha
Wed, 04/17/13 - 11:05 am
Vivus
Qsymia
Orexigen
obesity
Arena Pharmaceuticals
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Sat, 04/13/13 - 12:24 pm
Vivus
Cempra
Corcept Therapeutics
Risk plan change not enough for Vivus drug success: top investor
Reuters
Thu, 04/11/13 - 11:51 am
Vivus
Qsymia
obesity
Is Arena Really Launching A New Product And Expanding Its Pipeline?
Seeking Alpha
Tue, 04/9/13 - 02:48 pm
Arena Pharmaceuticals
Novartis
Vivus
As Arena Pharma Begins To Address Mexican Obesity, All Eyes Are Now On The DEA
Seeking Alpha
Mon, 04/8/13 - 11:39 am
Arena Pharmaceuticals
Mexico
obesity
Vivus
APD811
Belviq
Eisai
How Doctors Actually Diagnose Obesity
Motley Fool
Sun, 04/7/13 - 10:41 am
obesity
weight loss
Vivus
Arena Pharmaceuticals
Orexigen
Belviq
Qsymia
Contrave
Does The World Want, Much Less Need, A New Erectile Dysfunction Drug?
Forbes
Wed, 04/3/13 - 09:46 am
Avanafil
erectile dysfunction
Vivus
Stendra
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »